These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11525101)

  • 1. Meta-analysis of dietary restriction during fecal occult blood testing.
    Pignone M; Campbell MK; Carr C; Phillips C
    Eff Clin Pract; 2001; 4(4):150-6. PubMed ID: 11525101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary interventions for fecal occult blood test screening: systematic review of the literature.
    Konrad G
    Can Fam Physician; 2010 Mar; 56(3):229-38. PubMed ID: 20228305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet for fecal occult blood test screening: help or harm?
    Fletcher RH
    Eff Clin Pract; 2001; 4(4):180-2. PubMed ID: 11525106
    [No Abstract]   [Full Text] [Related]  

  • 5. Financial incentives for completion of fecal occult blood tests among veterans: a 2-stage, pragmatic, cluster, randomized, controlled trial.
    Kullgren JT; Dicks TN; Fu X; Richardson D; Tzanis GL; Tobi M; Marcus SC
    Ann Intern Med; 2014 Nov; 161(10 Suppl):S35-43. PubMed ID: 25402401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer.
    Cole SR; Young GP
    Med J Aust; 2001 Aug; 175(4):195-8. PubMed ID: 11587278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with fecal occult blood testing: the role of restrictive diets.
    Joseph A
    Am J Public Health; 1988 Jul; 78(7):839-41. PubMed ID: 3381964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
    Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
    Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dietary restriction in Haemoccult screening for colorectal cancer.
    Thomas WM; Pye G; Hardcastle JD; Chamberlain J; Charnley RM
    Br J Surg; 1989 Sep; 76(9):976-8. PubMed ID: 2679967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary restrictions and fecal occult blood testing.
    Coughlin RJ; Friend WG
    Am Fam Physician; 1987 May; 35(5):118-20. PubMed ID: 3577984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do dietary restrictions reduce fecal occult blood testing adherence?
    Richardson CR
    J Fam Pract; 2001 Dec; 50(12):1081. PubMed ID: 11742613
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
    Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
    Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.